MDsave Launches Discounted Mammogram Campaign
MDsave, the healthcare services platform connecting providers, employers, and patients to transactable healthcare, has launched its annual campaign to reduce the cost of 2D and 3D screening mammograms.
MDsave, the healthcare services platform connecting providers, employers, and patients to transactable healthcare, has launched its annual campaign to reduce the cost of 2D and 3D screening mammograms.
The Medical Imaging & Technology Alliance (MITA) has submitted comments to United States Preventive Services Task Force on its draft recommendation on breast cancer screening.
The Contrast-Enhanced Mammography Imaging Screening Trial, a clinical trial to determine if contrast-enhanced mammography improves breast cancer detection and reduces false-positive exams in women with dense breasts, has enrolled its first patients.
Breast cancer risk estimates for individual women vary substantially depending on which risk assessment model is used, and women are likely receiving vastly different recommendations depending on the model used and the cutoff applied to define “high risk.”
Read MoreAwareness of breast density appears to increase one’s perceived breast cancer risk for a short time after undergoing mammography, according to a new study.
Read MoreAccording to a new study, both menstrual status and menstrual cycle time are associated with the degree of early background parenchymal enhancement on contrast-enhanced mammography (CEM), which could influence CEM interpretations.
Read MoreA retrospective study of Seno Medical’s Imagio Breast Imaging System found that the company’s opto-acoustic/ultrasound technology significantly improves specificity at fixed sensitivity compared to conventional ultrasound.
Read MoreDigital health company MedCognetics, Inc. announces that it has received U.S. FDA 510(k) clearance of its artificial intelligence-enabled software for breast cancer screening, QmTRIAGE.
Read More